Related Experiment Video
Updated: Mar 8, 2026

Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70
Published on: August 9, 2019
Microalbuminuria is a late event in patients with hypertension: Do we need a lower threshold?
Mohamed Abdel Kader Abdel Wahab1, Mohamed Mohamed Saad1, Khaled Abdel Ghany Baraka1
1Department of Cardiology, El Minya, Egypt.
Background:
Microalbuminuria (MA) is a marker of vascular damage. However, many studies have observed an increased risk at lower levels of albuminuria than are currently used to define MA.
Aim:
To verify early cardiovascular changes occurring before MA in hypertensive patients.
Materials And Methods:
One hundred and fifty hypertensive patients and 60 normotensive individuals were divided into normotensive individuals with normal left ventricular (LV) geometry (Group I), hypertensive patients with normal LV geometry (Group II), and hypertensive patients with abnormal LV geometry (Group III). The LV mass index, ambulatory arterial stiffness index, flow-mediated dilatation of the brachial artery, and intima-media thickness (IMT) of the common carotid were assessed. Urinary albumin/creatinine ratio was determined using a morning spot-urine sample.
Results:
Compared with Group I, ambulatory arterial stiffness index and IMT were significantly increased and flow-mediated dilatation was significantly decreased in Group II; however, MA did not differ between both groups. These changes were augmented when Group III was compared with Group II. MA significantly increased in Group III compared with Group II. Receiver operating characteristic analysis revealed that MA, with a cut-off value of 19.25 mg/g, predicted increased IMT, and abnormal LV geometry in a statistically significant manner.
Conclusion:
Many vascular changes, in the form of increased IMT, reduced vasodilator capacity, and increased arterial stiffness, preceded MA and any change in LV geometry. The results presented here strengthen the usefulness of adopting a lower cut-off to define MA.
Insights
Vascular damage markers like increased intima-media thickness and arterial stiffness appear before microalbuminuria (MA) in hypertensive patients. These findings suggest a lower threshold for defining MA may improve early cardiovascular risk detection.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Hypertension Research
Background:
- Microalbuminuria (MA) is a recognized marker of vascular damage.
- Emerging evidence suggests increased cardiovascular risk at albuminuria levels below current MA definitions.
Purpose of the Study:
- To investigate early cardiovascular alterations preceding the onset of MA in hypertensive individuals.
- To assess subclinical vascular changes in hypertensive patients with varying left ventricular (LV) geometry.
Main Methods:
- Assessed LV mass index, ambulatory arterial stiffness index, flow-mediated dilatation, and carotid intima-media thickness (IMT) in 150 hypertensive and 60 normotensive individuals.
- Categorized participants into normotensive with normal LV geometry, hypertensive with normal LV geometry, and hypertensive with abnormal LV geometry.
- Measured urinary albumin/creatinine ratio (UACR) from spot urine samples.
Main Results:
- Hypertensive patients (Group II) showed increased arterial stiffness and IMT, and decreased flow-mediated dilatation compared to normotensive individuals (Group I), without differing MA levels.
- These vascular changes were more pronounced in hypertensive patients with abnormal LV geometry (Group III).
- MA significantly increased in Group III, and receiver operating characteristic analysis indicated MA (cut-off 19.25 mg/g) predicted increased IMT and abnormal LV geometry.
Conclusions:
- Subclinical vascular changes, including increased IMT, reduced vasodilator function, and heightened arterial stiffness, precede MA and alterations in LV geometry.
- These findings support the utility of a lower threshold for defining MA to identify early vascular damage.
- Early detection of vascular changes before MA may allow for timely intervention in hypertensive patients.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease I: Introduction
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention

